The risk that revisions to safety, food, and pharmaceutical regulations, as well as drug-price revisions, affecting multiple businesses including LP gas, Aqua, and Medical and Industrial Gas, will constrain business operations and earnings. This also includes new regulations concerning commercial practices, pricing systems, and information disclosure for LP gas.